Heparin Sodium In Sodium Chloride Injection
Product Images NDC 0264-9872

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Heparin Sodium In Sodium Chloride (NDC 0264-9872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Heparin Sodium Chemical Formula (Heparin Sodium In Sodium Chloride In Excel 1)

FDA Label Image

Symbol (Heparin Sodium In Sodium Chloride In Excel 2)

FDA Label Image

=4 (Heparin Sodium In Sodium Chloride In Excel 3)

FDA Label Image

Recycle 7 (Heparin Sodium In Sodium Chloride In Excel 4)

FDA Label Image

500 mL Container Label P8721 (Heparin Sodium In Sodium Chloride In Excel 5)

500 mL Container Label P8721 (Heparin Sodium In Sodium Chloride In Excel 5)
HEPARIN Sodium is a solution of 1,000 USP units per 500 mL containing 2 USP units per mL of Heparin Sodium USP obtained from porcine intestinal mucosa, along with Sodium Chloride USP and other ingredients in 0.9% Sodium Chloride Injection. It is not recommended to mix HEPARIN Sodium with other drugs, and it is designed for intravenous use only. Some of the key components in this solution include Dibasic Sodium Phosphates and Citric Acid Anhydrous USP with a room temperature storage requirement. Additionally, the container warns that it has SULFITES, and the overwrap should not be removed until it's ready for use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.